Overactive Bladder Innovative Therapy Trial (OrBIT)

Overactive Bladder Innovative Therapy Trial

The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).

Inclusion Criteria:

• Is at least 18 years of age
• Experiences OAB with a voiding frequency of at least 8 times per day
• Is ambulatory and able to use a toilet independently and without difficulty

Exclusion Criteria:

• On OAB pharmacotherapy within the previous month
• Primary complaint is stress urinary incontinence
• Has pacemaker or implantable defibrillator
• Has history of heart problems
• Has nerve damage or neuropathy
• Has gastric or urinary retention
• Has uncontrolled narrow-angle glaucoma
• Has known sensitivity to drug ingredients
• Is pregnant or planning to become pregnant during the trial